ID24346A - OF BETHA-AMINO AND BETHA -AZIDO ACID CARBOXICATE ACID, MAKING AND USING IT AS ANDOTELIN RECEPTOR ANTAGONISTS - Google Patents

OF BETHA-AMINO AND BETHA -AZIDO ACID CARBOXICATE ACID, MAKING AND USING IT AS ANDOTELIN RECEPTOR ANTAGONISTS

Info

Publication number
ID24346A
ID24346A IDW991614A ID991614A ID24346A ID 24346 A ID24346 A ID 24346A ID W991614 A IDW991614 A ID W991614A ID 991614 A ID991614 A ID 991614A ID 24346 A ID24346 A ID 24346A
Authority
ID
Indonesia
Prior art keywords
betha
acid
carboxicate
andotelin
amino
Prior art date
Application number
IDW991614A
Other languages
Indonesian (id)
Inventor
Wilhelm Amberg
Andreas Kling
Dagmar Klinge
Hartmut Riechers
Stefan Hergenroder
Manfred Raschack
Liliane Unger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ID24346A publication Critical patent/ID24346A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C07D237/16—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW991614A 1997-06-19 1998-06-05 OF BETHA-AMINO AND BETHA -AZIDO ACID CARBOXICATE ACID, MAKING AND USING IT AS ANDOTELIN RECEPTOR ANTAGONISTS ID24346A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19726146A DE19726146A1 (en) 1997-06-19 1997-06-19 New ß-amino and ß-azidopcarboxylic acid derivatives, their preparation and use as endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
ID24346A true ID24346A (en) 2000-07-13

Family

ID=7833081

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991614A ID24346A (en) 1997-06-19 1998-06-05 OF BETHA-AMINO AND BETHA -AZIDO ACID CARBOXICATE ACID, MAKING AND USING IT AS ANDOTELIN RECEPTOR ANTAGONISTS

Country Status (22)

Country Link
EP (1) EP0994861A1 (en)
JP (1) JP2002504130A (en)
KR (1) KR20010013981A (en)
CN (1) CN1261352A (en)
AR (1) AR015893A1 (en)
AU (1) AU8213398A (en)
BG (1) BG104022A (en)
BR (1) BR9810182A (en)
CA (1) CA2294050A1 (en)
CO (1) CO4950605A1 (en)
DE (1) DE19726146A1 (en)
HR (1) HRP980331A2 (en)
HU (1) HUP0002714A3 (en)
ID (1) ID24346A (en)
IL (1) IL133104A0 (en)
NO (1) NO996268D0 (en)
NZ (1) NZ502319A (en)
PL (1) PL337507A1 (en)
SK (1) SK176299A3 (en)
TR (1) TR199903159T2 (en)
WO (1) WO1998058916A1 (en)
ZA (1) ZA985277B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19806438A1 (en) * 1998-02-17 1999-08-19 Basf Ag New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer
DE19858779A1 (en) * 1998-12-18 2000-06-21 Basf Ag New 3-acylamino-propionic acid and 3-sulfonylamino-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiovascular and renal disorders, migraine and cancer
DE19924892A1 (en) * 1999-06-01 2000-12-07 Basf Ag New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their production and use as endothelin receptor antagonists
WO2002064573A1 (en) * 2001-02-14 2002-08-22 Abbott Gmbh & Co. Kg Novel carboxylic acid derivatives containing alkyl substituted triazines, production of the same and use thereof as endothelin receptor antagonists
EP1632821B1 (en) 2004-09-01 2012-05-30 Océ-Technologies B.V. Intermediate transfer member with a cleaning member
US7790770B2 (en) * 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
AU2008282773B8 (en) 2007-07-31 2013-03-07 Gilead Sciences, Inc. Metabolites and derivatives of ambrisentan
CN109422664B (en) * 2017-08-23 2022-02-18 中国科学院福建物质结构研究所 Interferon regulator and its prepn and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
DE4411225A1 (en) * 1994-03-31 1995-10-05 Basf Ag Use of carboxylic acid derivatives as a drug
DE19614533A1 (en) * 1996-04-12 1997-10-16 Basf Ag New alpha-hydroxy acid derivatives, their production and use

Also Published As

Publication number Publication date
DE19726146A1 (en) 1998-12-24
AU8213398A (en) 1999-01-04
CN1261352A (en) 2000-07-26
HRP980331A2 (en) 1999-02-28
ZA985277B (en) 1999-12-20
HUP0002714A2 (en) 2001-05-28
IL133104A0 (en) 2001-03-19
CA2294050A1 (en) 1998-12-30
AR015893A1 (en) 2001-05-30
NO996268L (en) 1999-12-17
JP2002504130A (en) 2002-02-05
KR20010013981A (en) 2001-02-26
BG104022A (en) 2001-04-30
WO1998058916A1 (en) 1998-12-30
PL337507A1 (en) 2000-08-28
BR9810182A (en) 2000-08-08
HUP0002714A3 (en) 2001-07-30
SK176299A3 (en) 2000-06-12
CO4950605A1 (en) 2000-09-01
TR199903159T2 (en) 2000-07-21
NZ502319A (en) 2002-03-01
NO996268D0 (en) 1999-12-17
EP0994861A1 (en) 2000-04-26

Similar Documents

Publication Publication Date Title
ID19253A (en) VITRONEKTIN RECEPTOR ANTAGONISTS, ITS MANUFACTURE AND USE OF IT
ID26099A (en) AMIDA DEGREE AND NOSICEPTIN ANTAGONISTS
ID26248A (en) NEW ASIGUANIDINE DECREASED AS BONE ABSORPTION INHIBITOR AND AS VITRONECTTIN RECEPTOR ANTAGONISTS
ID19417A (en) NEW CARBOXICATE ACID DERIVATIVES, PRODUCTION AND USE AS AN A / ET b RECEPTOR ANTAGONISTS MIXED
ID26420A (en) NEW SUBSTITUTED INDOLINONS, THEIR PRODUCTION AND USE AS PHARMACEUTICAL COMPOSITIONS
ID19623A (en) VITRONEKTIN RECEPTOR ANTAGONISTS
ID24929A (en) DURUNAN 2-ARIL-8-OXYODIHYDRROPURIN, THE PROCESS OF MAKING IT, THE COMPOSITION OF THE PHARMACY THAT CONTAINS IT, AND ITS COMPOUND
PT1009732E (en) 1-AMINO-ALKYLCICLO-HEXANES ANTAGONISTS OF THE NMDA RECEPTOR
DE69812096T2 (en) NEUROPEPTID Y RECEPTOR ANTAGONISTS
ID19245A (en) VITRONEKTIN RECEPTOR ANTAGONISTS, THE PRODUCTION AND USE OF IT
ID16742A (en) ENDOTELIN RECEPTOR ANTAGONISTS
ID26774A (en) BENZIMIDAZOL COMPOUNDS, MAKING AND USE AS A PHARMACY COMPOSITION
ID25591A (en) META-AZASICLIC AMINO BENZOAT ACID COMPOUNDS AND ITS DECLARATION ARE INTEGRIN ANTAGONISTS
DE69823694T2 (en) THROMBIN RECEPTOR ANTAGONISTS
ID26223A (en) VITRONEKTIN RECEPTOR ANTAGONISTS
IS5331A (en) New pharmaceutical mix
ID16274A (en) FLUOROALCYL AND FLUOROALCOCY, HETEROSICLIC ANTAGONIST ANALYSIS, PRODUCTION PROCESS AND USE OF ITS
ID22911A (en) NEW TRIAZOL DISTRICTS, THE PROCESS OF MAKING AND THE PHARMACY COMPOSITION CONTAINING IT
ID24346A (en) OF BETHA-AMINO AND BETHA -AZIDO ACID CARBOXICATE ACID, MAKING AND USING IT AS ANDOTELIN RECEPTOR ANTAGONISTS
ID30484A (en) DERUNAN 4-HETEROSICLICSULFONAMIDYL 6 METHODS 5 (2 PHENOXIC METHODS) 2 PYRIDYL-PYRIMIDINS, THEIR PRODUCTION AND USE AS ANTAGONISTS OF ENDOTELINE RECEPTORS
ID24468A (en) 2-ACYLAMINOPROPANAMINA AS TACHYKININ RECEPTOR ANTAGONISTS
ID24278A (en) NEW CARBOXICATE ACID DERIVES WITH AMIDA SIDE CHAIN, MANUFACTURING AND USING IT AS ENDOTELINE ANTAGONIC RECEPTORS
ID28811A (en) VITRONEKTIN RECEPTOR ANTAGONISTS
ID26234A (en) HETEROSICLIC CARBOXICATE ACID DECREASES, PRODUCTION AND USE AS ENDOTELEN RECEPTOR ANTAGONISTS
ID20967A (en) CHRISTANTS SUBSTITUTED SULFONAMIDE, THE PROCESS OF MAKING, USE AS A MEDICINE, AND PHARMACEUTICAL PROPERTIES THAT CONTAIN SUCH MATERIALS